ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
0 comments
Press
October 12, 2023
12 Oct 2023

Invitation to digital live presentation with Acarix

Acarix, a leader in acoustic and AI-based cardiac diagnostics, invites to a digital investor presentation on Friday October 13, 2023 at...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Oct 2023

Acarix publishes prospectus in connection with the company’s fully guaranteed rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Oct 2023

Acarix offentliggör prospekt i samband med bolagets fullt garanterade företrädesemission

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HONGKONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
02 Oct 2023

Acarix appoints industry veteran Fred Colen as acting CEO during temporary medical leave of CEO Helen Ljungdahl Round

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces that CEO Helen Ljungdahl Round will be taking a temporary medi...
Continue reading
author-avatar acarix
Press
August 6, 2024
02 Oct 2023

Acarix utser industriledaren Fred Colen som tillförordnad VD medan VD Helen Ljungdahl Round tillfälligt sjukskrivs

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att VD Helen Ljungdahl Round sjukskrivits för behandling av...
Continue reading
author-avatar acarix
Press
August 6, 2024
28 Sep 2023

Announcement from Acarix’s extra general meeting

The extra general meeting of Acarix AB ("Acarix" or the "Company") was held today on 28 September 2023 and the foll...
Continue reading
author-avatar acarix
Press
August 6, 2024
28 Sep 2023

Kommuniké från extra bolagsstämma i Acarix

Extra bolagsstämma i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 28 september 2023 varvid aktieägarna fatta...
Continue reading
author-avatar acarix
Press
August 6, 2024
27 Sep 2023

Acarix expands use of CADScor System into Osteopathic Medicine

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces expanded utilization of the CADScor® System into the fir...
Continue reading
author-avatar acarix
Press
August 6, 2024
27 Sep 2023

Acarix utökar användningen av CADScor System inom osteopatisk medicin

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag den första affären inom osteopatisk medicin på USA-marknade...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Sep 2023

Acarix byter Certified Adviser till Penser Bank AB

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att man byter Certified Adviser. Acarix AB har ingått avtal...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Sep 2023

Acarix changes Certified Adviser to Penser Bank AB

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces a change of Certified Adviser. Acarix AB has entered int...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Sep 2023

Notice of Extra General Meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the extra general meeting to be ...
Continue reading
  • «
  • ‹
  • 6
  • 7
  • 8
  • 9
  • 10
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.